Key Benefits:
240. Ordinance of the Federal Minister of Health, with which the prescription of the prescription of the prescription is changed
On the basis of § 2 para. 1 prescription law, BGBl. No 413/1972, as last amended by the Federal Law BGBl. I n ° 115/2008 and the Federal Ministries of the Federal Ministries of Law 2009, BGBl. I No 3, shall be assigned:
The prescription decree, BGBl. No 475/1973, as last amended by BGBl. II No 183/2009, shall be amended as follows:
The list of Annex A. Medicinal products for human use, part 2 human, shall be supplemented at the appropriate alphabetical points as follows:
ABARELIX NO
AGOMELATIN NO
5-Aminolaevulinic acid RP
AZACITIDIN NO
BAZEDOXIFEN NO
BILASTIN RP
CANAKINUMAB NO
CATUMAXOMAB NO
CERTOLIZUMAB NO
DAPOXETIN NO
DEGARELIX NO
EPOETIN THETA NO
ESLICARBAZEPIN RP
GEFITINIB NO
GOLIMUMAB NO
HISTRELIN NO
LASOFOXIFEN NO
LIRAGLUTID NO
MIFAMURTID NO
PLERIXAFOR NO
PRASUGREL RP
PRUCALOPRIDE RP
RILONACEPT NO
ROMIPLOSTIM NO
SAPROPTERIN NO
SAXAGLIPTIN NO
TOCILIZUMAB NO
TOCOFERSOLAN RP
TOLVAPTAN NO
ULIPRISTAL RP
STEKINUMAB NO
VINFLUNIN NO
The list of Annex A. Medicinal products for human use, part 2 human, shall be amended as follows:
FEXOFENADIN RP
is replaced by
FEXOFENADIN RPF
NAPHAZOLIN RP, R86, Ryy, W1
is replaced by
NAPHAZOLIN RP, R86, R93, W1
PROPYPHENAZON RPF, W 7, W 17
is replaced by
PROPYPHENAZON RP
PANTOPRAZOLE RP
is replaced by
PANTOPRAZOLE RP, R97
TYLOXAPOL RP
is deleted
3. Annex I to Annex A. Medicinal products for human use shall be included in the following collection of products:
R 97 excluded for the short-term treatment of reflux symptoms (e. g. heartburn, acid refluxing) in adults up to 20 mg per day
The list of Annex B. Veterinary medicinal products, part 2 veterinarian, shall be supplemented at the appropriate alphabetical points as follows:
MASITINIB NO
PEFORELIN RP
ROBENACOXIB RP
TOCERANIB NO